• 제목/요약/키워드: Pharmaceutical Society of Korea

검색결과 10,548건 처리시간 0.037초

Potentially Cytotoxic Triterpenoids from the Root Bark of Siphonodon celastrineus Griff.

  • Niampoka, Chokchai;Suttisri, Rutt;Bavovada, Rapepol;Takayama, Hiromitsu;Aimi, Norio
    • Archives of Pharmacal Research
    • /
    • 제28권5호
    • /
    • pp.546-549
    • /
    • 2005
  • A new oleanane-triterpene, 3${\beta}$-acetoxy-11${\alpha}$-benzoyloxy-13${\beta}$-hydroxyolean-1 2-one (1), was isolated along with a known quinone-methide triterpene, pristimerin (2), from the root bark of Siphonodon celastrinneus Griff., a Thai medicinal plant of the family Celastraceae. Their structures were determined based on spectroscopic analysis.

Cytotoxic Constituents form the Roots of Anthriscus sylvestris

  • Lim, Young-Hee;Leem, Moon-Jeong;Shin, Dong-Hyuk;Chang, Hwan-Bong;Hong, Seung-Woo;Moon, Eun-Yi;Lee, Dug-Keun;Yoon, Sung-June;Woo, Won-Sick
    • Archives of Pharmacal Research
    • /
    • 제22권2호
    • /
    • pp.208-212
    • /
    • 1999
  • Activity-guided fractionation of the roots of Anthriscus sylvestris resulted in the isolated and characterization of five cytotoxic compounds, deoxypodophyllotoxin (1), falcarindiol (2), and angeloyl podophyllotoxin (5) from the hexane soluble fraction and morelensin (3), bursehernin (4) from the choloroform soluble fraction. It is the first report of the occurrence of compound 5 in nature.

  • PDF

Attenuation of monocrotaline-induced pulmonary hypertension with DA-8159, a potent PDE 5 inhibitor

  • Ahn, Gook-Jun;Kang, Kyung-Koo;Sohn, Yong-Sung;Choi, Seu-Min;Kim, Ju-Mi;Kim, Dong-Hwan;Ahn, Byoung-Ok;Kim, Won-Bae
    • 대한약학회:학술대회논문집
    • /
    • 대한약학회 2002년도 Proceedings of the Convention of the Pharmaceutical Society of Korea Vol.2
    • /
    • pp.249.1-249.1
    • /
    • 2002
  • This study was carried out to demonstrate the effects of oral administration of DA-8159. a selective phosphodiesterase 5 inhibitor. on development of pulmonary hypertension induced by monocrotaline (MCT). MCT-treated rats(60mg/kg) were divided into three groups and orally administered vehicle, 1 mg/kg or 5 mg/kgg of DA-8159 twice a day for 3 weeks. Increased right ventricular weights, medial wall thickening in pulmonary arteries. myocardial fibrosis, decrease of plasma cyclic guanosine monophosphate (cGMP) level and body weight gains were shown in MCT group. (omitted)

  • PDF

우리나라 GMP 변천사 (The History of Korean GMP)

  • 백우현
    • 약학회지
    • /
    • 제59권1호
    • /
    • pp.40-46
    • /
    • 2015
  • The term "GMP" firstly came on the 1962 amendment of the Federal Food, Drug and Cosmetic (FD&C) Act and the US FDA established and officially announced the Good Manufacturing Practice Regulation for the first time in the world in 1963. In 1969, the World Health Organization published the GMP regulation and recommended that member states adopt the GMP regulation and implement the "GMP Certification Scheme" for international commerce of finished pharmaceutical products. As a result, GMP requirements have become important ones that have to be complied with in the manufacture of pharmaceutical products. The Korean GMP regulation was announced as the official notification by the Ministry of Health and Social Affairs in 1977. The KGMP regulation was voluntarily adopted by pharmaceutical companies at the early stage, but it had become mandatory. In addition, various kinds of GMP regulations have been established to cover active pharmaceutical ingredients, biological products and others, in addition to finished pharmaceutical products. Taking account of technological development and changes in the pharmaceutical environments, the KGMP regulation was fully amended and harmonized with GMP requirements of developed countries. In this way, the KGMP has developed to keep up with international trends and standards, leading to accession to the Pharmaceutical Inspection Cooperation Scheme (PIC/S).

Proficiency Test for Pharmaceutical Companies in Analyzing Drug Products (I) - Comparison of Criteria for Satisfactory Test Results

  • Cho, Jung-Hwan;Sung, Jun-Hyun;Choi, Seon-Hee;Choi, Jang-Duck;Lee, Seung-Kyung;Chae, Kab-Ryong;Moon, Byung-Woo
    • 대한약학회:학술대회논문집
    • /
    • 대한약학회 2002년도 Proceedings of the Convention of the Pharmaceutical Society of Korea Vol.2
    • /
    • pp.398.3-399
    • /
    • 2002
  • Quality control by analytical ability with a certain level of precision and accuracy is important. This is true especially in pharmaceutical industries. for a failure in quality control can result in a failure in drug medication. in turn. sometimes a heavy damage to patient's health condition andlor the worst damage to company's reputation. On this backgroun, Kyungki KFDA prepared test pharmaceutical products, which were distributed to 114 pharmaceutical companies in kyungin Province in year 2000. (omitted)

  • PDF

Cytotoxicity of Trichothecenes to Human Solid Tumor Cells in Vitro

  • Choi, Sang-Un;Choi, Eun-Jung;Kim, Kwang-Hee;Kim, Nam-Young;Kwon, Byung-Mog;Kim, Sung-Uk;Bok, Song-Hae;Lee, So-Young;Lee, Chong-Ock
    • Archives of Pharmacal Research
    • /
    • 제19권1호
    • /
    • pp.6-11
    • /
    • 1996
  • The trichothecenes are sesquiterpenoid mycotoxins characterized by the 12,13-epoxytrichothec-9-ene ring system. We have tested cytotoxicity of several naturally-occurring or synthesized trichothecenes against human solid tumor cell lines. Among them, trichothecin(I) and $4-\beta$-Acetoxy-12,13-epoxytrichothec-9-ene (trichodermin, II) exhibited highly cytotoxic activities. 4-.betha.-Hydroxy-12,13-epoxytrichothec-9-ene (trichodermol, III) and $4-\beta$-Methoxy-12,13-epoxytrichothec-9-ene (IV) had mild cytotoxicities. But 12,13-Epoxytrichothec-9-ene-4-one (V) and $4-\beta$-Hydroxy-12,13-epoxytrichothec-9-ene(VI) had no cytotoxicities up to 10 $\mug/ml$. And in the tested cell lines, HCT15 colon cancer cell line was the most sensitive to all tested trichothecenes.

  • PDF

Construction of Database and Analysis of Specifications of Pharmaceutical Agents Listed in Korean Compendiums

  • Cho, Jung-Hwan
    • 대한약학회:학술대회논문집
    • /
    • 대한약학회 2003년도 Proceedings of the Convention of the Pharmaceutical Society of Korea Vol.2-2
    • /
    • pp.221.2-221.2
    • /
    • 2003
  • Several Compendia are effective in relation with production and supply of pharmaceutical agents in Korea. Those compendia exists only in printed documents, which are not suitable for the analysis of their contents and inter-relationship among them when they have specifications on the same or related pharmaceutical agents. For the analysis of contents of Korean compendia, database system is desinged and all of the available data are entered into relational database system. Every specification was analyzed into several database tables, fields and relations between tables. (omitted)

  • PDF

의약품에 사용되는 유리용기의 용출알카리도에 대하여 (Studies on the alkalinity of pharmaceutical containers)

  • 김상민;이규송
    • 약학회지
    • /
    • 제12권1_2호
    • /
    • pp.35-39
    • /
    • 1968
  • Alkalinity of pharmaceutical containers is to be highly influenced for liquid pharmaceuticals. The criteria of the alkalinity of ampoules and vials used as pharmaceutical containers is established in the Korean Pharmacopoeia. However, the criteria of general containers for liquid pharmaceuticals is not eatablished in the Korean Pharmacopoeia. Therefore, we tried to perform comparing test for domestic products and foreign products of following group: 1) vials 2) general containers for liquid pharmaceutical 3) general containers for tablet pharmaceuticals It was found that the domestically produced vials were good enough for criteria, while almost fifty percent of non-established containers was unsaticefactory.

  • PDF